Delivery Order SPE2DB22D1106-SPE2DB25FETC3

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,074.77 delivery order contract to Amerisourcebergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a firm fixed price and an ultimate completion date of September 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for delivering a wide range of medical commodities to support military treatment programs....
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,900.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565177698 ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,900.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies in support of military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,161.29 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a prescription medication, with a completion date of June 7, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Firm Fixed Price delivery order contract, worth $5,620.74, to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which AmerisourceBergen holds with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,800.16 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564016271 ELIQUIS 2.5 MG TABLET 60S. This delivery order is a part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $3,851.90 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567732654 ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,956.86, is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,599.60 firm fixed price delivery order contract to provide ELIQUIS 5 MG TABLET 60S. This order falls under a larger, single-award, indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $1,138.90 firm fixed price delivery order is for the supply of ELIQUIS 2.5 MG TABLET 60S medication to the DLA. The contract has an ultimate completion date of May 27, 2025 and was awarded on May 23, 2025. This appears to be a stand-alone delivery order rather than part of a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FETC3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,965.60 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ELIQUIS 2.5 MG TABLET 60S. This contract is not set aside and has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/10/25, 10:07 AM